-
Je něco špatně v tomto záznamu ?
Nanofiber Wound Dressing Materials-A Comparative Study of Wound Healing on a Porcine Model
K. Menclová, P. Svoboda, J. Hadač, Š. Juhás, J. Juhásová, J. Pejchal, V. Mandys, K. Eminger, M. Ryska
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
33959775
DOI
10.1093/milmed/usab155
Knihovny.cz E-zdroje
- MeSH
- chitosan * farmakologie terapeutické užití MeSH
- hojení ran MeSH
- nanovlákna * terapeutické užití MeSH
- obvazy MeSH
- prasata MeSH
- sérový amyloid A farmakologie MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Nanofiber wound dressings remain the domain of in vitro studies. The purpose of our study was to verify the benefits of chitosan (CTS) and polylactide (PLA)-based nanofiber wound dressings on a porcine model of a naturally contaminated standardized wound and compare them with the conventional dressings, i.e., gauze and Inadine. MATERIAL AND METHODS: The study group included 32 pigs randomized into four homogeneous groups according to the wound dressing type. Standardized wounds were created on their backs, and wound dressings were regularly changed. We evaluated difficulty of handling individual dressing materials and macroscopic appearance of the wounds. Wound swabs were taken for bacteriological examination. Blood samples were obtained to determine blood count values and serum levels of acute phase proteins (serum amyloid A, C-reactive protein, and haptoglobin). The crucial point of the study was histological analysis. Microscopic evaluation was focused on the defect depth and tissue reactions, including formation of the fibrin exudate with neutrophil granulocytes, the layer of granulation and cellular connective tissue, and the reepithelialization. Statistical analysis was performed by using SPSS software. The analysis was based on the Kruskal-Wallis H test and Mann-Whitney U test followed by Bonferroni correction. Significance was set at P < .05. RESULTS: Macroscopic examination did not show any difference in wound healing among the groups. However, evaluation of histological findings demonstrated that PLA-based nanofiber dressing accelerated the proliferative (P = .025) and reepithelialization (P < .001) healing phases, while chitosan-based nanofiber dressing potentiated and accelerated the inflammatory phase (P = .006). No statistically significant changes were observed in the blood count or acute inflammatory phase proteins during the trial. Different dynamics were noted in serum amyloid A values in the group treated with PLA-based nanofiber dressing (P = .006). CONCLUSION: Based on the microscopic examination, we have documented a positive effect of nanofiber wound dressings on acceleration of individual phases of the healing process. Nanofiber wound dressings have a potential to become in future part of the common wound care practice.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23004658
- 003
- CZ-PrNML
- 005
- 20230425171640.0
- 007
- ta
- 008
- 230418s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/milmed/usab155 $2 doi
- 035 __
- $a (PubMed)33959775
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Menclová, Katerina $u Department of Surgery, 2nd Faculty of Medicine, Military University Hospital Prague and Charles University, Prague 169 02, Czechia
- 245 10
- $a Nanofiber Wound Dressing Materials-A Comparative Study of Wound Healing on a Porcine Model / $c K. Menclová, P. Svoboda, J. Hadač, Š. Juhás, J. Juhásová, J. Pejchal, V. Mandys, K. Eminger, M. Ryska
- 520 9_
- $a BACKGROUND: Nanofiber wound dressings remain the domain of in vitro studies. The purpose of our study was to verify the benefits of chitosan (CTS) and polylactide (PLA)-based nanofiber wound dressings on a porcine model of a naturally contaminated standardized wound and compare them with the conventional dressings, i.e., gauze and Inadine. MATERIAL AND METHODS: The study group included 32 pigs randomized into four homogeneous groups according to the wound dressing type. Standardized wounds were created on their backs, and wound dressings were regularly changed. We evaluated difficulty of handling individual dressing materials and macroscopic appearance of the wounds. Wound swabs were taken for bacteriological examination. Blood samples were obtained to determine blood count values and serum levels of acute phase proteins (serum amyloid A, C-reactive protein, and haptoglobin). The crucial point of the study was histological analysis. Microscopic evaluation was focused on the defect depth and tissue reactions, including formation of the fibrin exudate with neutrophil granulocytes, the layer of granulation and cellular connective tissue, and the reepithelialization. Statistical analysis was performed by using SPSS software. The analysis was based on the Kruskal-Wallis H test and Mann-Whitney U test followed by Bonferroni correction. Significance was set at P < .05. RESULTS: Macroscopic examination did not show any difference in wound healing among the groups. However, evaluation of histological findings demonstrated that PLA-based nanofiber dressing accelerated the proliferative (P = .025) and reepithelialization (P < .001) healing phases, while chitosan-based nanofiber dressing potentiated and accelerated the inflammatory phase (P = .006). No statistically significant changes were observed in the blood count or acute inflammatory phase proteins during the trial. Different dynamics were noted in serum amyloid A values in the group treated with PLA-based nanofiber dressing (P = .006). CONCLUSION: Based on the microscopic examination, we have documented a positive effect of nanofiber wound dressings on acceleration of individual phases of the healing process. Nanofiber wound dressings have a potential to become in future part of the common wound care practice.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a prasata $7 D013552
- 650 12
- $a nanovlákna $x terapeutické užití $7 D057139
- 650 12
- $a chitosan $x farmakologie $x terapeutické užití $7 D048271
- 650 _2
- $a sérový amyloid A $x farmakologie $7 D000685
- 650 _2
- $a hojení ran $7 D014945
- 650 _2
- $a obvazy $7 D001458
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Svoboda, Petr $u Department of Surgery, 2nd Faculty of Medicine, Military University Hospital Prague and Charles University, Prague 169 02, Czechia
- 700 1_
- $a Hadač, Jan $u Department of Surgery, 2nd Faculty of Medicine, Military University Hospital Prague and Charles University, Prague 169 02, Czechia
- 700 1_
- $a Juhás, Štefan $u Institute of Animal Physiology and Genetics of the Academy of Sciences CR, Lib ěchov 277 21, Czechia
- 700 1_
- $a Juhásová, Jana $u Institute of Animal Physiology and Genetics of the Academy of Sciences CR, Lib ěchov 277 21, Czechia
- 700 1_
- $a Pejchal, Jaroslav $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Hradec Králové 500 02, Czechia
- 700 1_
- $a Mandys, Václav $u Department of Pathology, 3rd Faculty of Medicine, Charles University, University Hospital Královské Vinohrady, Prague 100 34, Czechia
- 700 1_
- $a Eminger, Karel $u Department of Scientific Information and Clinical Studies, Central Military University Hospital Prague, Prague 169 02, Czechia
- 700 1_
- $a Ryska, Miroslav $u Department of Surgery, 2nd Faculty of Medicine, Military University Hospital Prague and Charles University, Prague 169 02, Czechia
- 773 0_
- $w MED00003360 $t Military medicine $x 1930-613X $g Roč. 188, č. 1-2 (2023), s. e133-e139
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33959775 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425171636 $b ABA008
- 999 __
- $a ok $b bmc $g 1925007 $s 1190867
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 188 $c 1-2 $d e133-e139 $e 2023Jan04 $i 1930-613X $m Military medicine $n Mil Med $x MED00003360
- LZP __
- $a Pubmed-20230418